Company · CIK 0002029039 · SIC 2834 — Pharmaceutical Preparations · NYSE
Nasus Pharma Ltd · NSRX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 17, 2026 PForm 4 → | Jun 22, 7:12 am EDT | Dan Benjamin TelemanChief Executive Officer, Director | 6,550 | $3.10 | $20,305 | 163,541 | +4.17% |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.